BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12762632)

  • 1. Gain of function TSH receptor mutations and iodine deficiency: implications in iodine prophylaxis.
    Tonacchera M; Vitti P; De Servi M; Agretti P; De Marco G; Chiovato L; Pinchera A
    J Endocrinol Invest; 2003; 26(2 Suppl):2-6. PubMed ID: 12762632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic multinodular goiter in the elderly.
    Vitti P; Rago T; Tonacchera M; Pinchera A
    J Endocrinol Invest; 2002; 25(10 Suppl):16-8. PubMed ID: 12508907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism].
    Derwahl M
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():25-8. PubMed ID: 10355046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations.
    Krohn K; Wohlgemuth S; Gerber H; Paschke R
    J Pathol; 2000 Sep; 192(1):37-42. PubMed ID: 10951398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of toxic thyroid adenomas and nodules: relevance of activating mutations in the TSH-receptor and Gs-alpha gene, the possible role of iodine deficiency and secondary and TSH-independent molecular mechanisms.
    Derwahl M; Manole D; Sobke A; Broecker M
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S6-9. PubMed ID: 9867188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
    Paschke R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multinodular goiter. Epidemiology and prevention].
    Pinchera A; Aghini-Lombardi F; Antonangeli L; Vitti P
    Ann Ital Chir; 1996; 67(3):317-25. PubMed ID: 9019982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular aetiology of nodular goitre -- consequences for therapy?].
    Brauer VF; Paschke R
    Zentralbl Chir; 2004 Oct; 129(5):356-62. PubMed ID: 15486785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyroid diseases in sub-Saharan Africa].
    Sidibé el H
    Sante; 2007; 17(1):33-9. PubMed ID: 17897900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of mutations in the TSHr and Gsalpha genes in TSHr antibody negative Graves' disease.
    Elgadi A; Frisk T; Larsson C; Wallin G; Höög A; Zedenius J; Norgren S
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):516-21. PubMed ID: 16235153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutations in thyroid nodular disease.
    Krohn K; Paschke R
    Mol Genet Metab; 2002 Mar; 75(3):202-8. PubMed ID: 11914031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiopathology of iodine deficiency].
    Pinchera A; Rago T; Vitti P
    Ann Ist Super Sanita; 1998; 34(3):301-5. PubMed ID: 10052165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular aspects in the pathogenesis of nodules and adenomas of the thyroid gland].
    Derwahl M
    Schweiz Med Wochenschr; 1994 Sep; 124(37):1613-8. PubMed ID: 7939528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular goiter and goiter nodules: Where iodine deficiency falls short of explaining the facts.
    Derwahl M; Studer H
    Exp Clin Endocrinol Diabetes; 2001; 109(5):250-60. PubMed ID: 11507648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the TSHR (thyrotropin receptor) gene on chromosome 14q31 are not associated with mental retardation in the iodine-deficient areas of China.
    Guo TW; Zhang FC; Gao JJ; Bian L; Gao XC; Ma J; Yang M; Ji Q; Duan SW; Zheng ZJ; Li RL; Feng GY; St Clair D; He L
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):179-84. PubMed ID: 15911145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multinodular goitre: 'much more to it than simply iodine deficiency'.
    Derwahl M; Studer H
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):577-600. PubMed ID: 11289736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter].
    Hu FN; Jin Y; Teng WP; Yang F; Teng XC; Gao TS; Wang WB; Shi XG; Tao CM
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):936-9. PubMed ID: 12899791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of the TSH receptor.
    Duprez L; Parma J; Van Sande J; Rodien P; Sabine C; Abramowicz M; Dumont JE; Vassart G
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():295-302. PubMed ID: 10698593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.